Pharmacokinetics and molecular modification: implications in drug design and evaluation.
D000667:Ampicillin / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents; D001702:Biopharmaceutics; D002981:Clindamycin / Q000378:metabolism; D003023:Cloxacillin / Q000378:metabolism; D003561:Cytarabine / Q000378:metabolism; D003597:Cytosine Nucleotides / Q000378:metabolism; D004917:Erythromycin / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007700:Kinetics; D008034:Lincomycin / Q000378:metabolism; D009705:Nucleosides / Q000378:metabolism; D010406:Penicillins / Q000097:blood / Q000378:metabolism; D004364:Pharmaceutical Preparations; D010600:Pharmacology; D012107:Research Design; D013329:Structure-Activity Relationship; D013752:Tetracycline / Q000378:metabolism
D000900:Anti-Bacterial Agents; D003597:Cytosine Nucleotides; D009705:Nucleosides; D010406:Penicillins; D004364:Pharmaceutical Preparations; D003561:Cytarabine; D002981:Clindamycin; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D013752:Tetracycline; D003023:Cloxacillin